Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar Network.
Bipolar disorder
Comorbidity
Social functioning
Journal
International journal of bipolar disorders
ISSN: 2194-7511
Titre abrégé: Int J Bipolar Disord
Pays: Germany
ID NLM: 101622983
Informations de publication
Date de publication:
16 Dec 2019
16 Dec 2019
Historique:
received:
06
09
2019
accepted:
05
11
2019
entrez:
17
12
2019
pubmed:
17
12
2019
medline:
17
12
2019
Statut:
epublish
Résumé
Impairments in psychosocial functioning have been demonstrated in 30-60% of adults with bipolar disorder (BD). However, the majority of studies investigating the effect of comorbid mental health disorders and age at onset outcomes in BD have focused on traditional outcome measures such as mood symptoms, mortality and treatment response. Therefore, this project aimed to investigate the impact of comorbid mental health disorders and age at onset on longitudinal psychosocial outcome in participants with BD. Mixed effects modelling was conducted using data from the Stanley Foundation Bipolar Network. Baseline factors were entered into a model, with Global Assessment of Functioning (GAF) score as the longitudinal outcome measure. Relative model fits were calculated using Akaike's Information Criterion. No individual comorbidities predicted lower GAF scores, however an interaction effect was demonstrated between attention deficit hyperactivity disorder (ADHD) and any anxiety disorder (t = 2.180, p = 0.030). Participants with BD I vs BD II (t = 2.023, p = 0.044) and those in the lowest vs. highest income class (t = 2.266, p = 0.024) predicted lower GAF scores. Age at onset (t = 1.672, p = 0.095) did not significantly predict GAF scores. This is the first study to demonstrate the negative psychosocial effects of comorbid anxiety disorders and ADHD in BD. This study adds to the growing database suggesting that comorbid mental health disorders are a significant factor hindering psychosocial recovery.
Sections du résumé
BACKGROUND
BACKGROUND
Impairments in psychosocial functioning have been demonstrated in 30-60% of adults with bipolar disorder (BD). However, the majority of studies investigating the effect of comorbid mental health disorders and age at onset outcomes in BD have focused on traditional outcome measures such as mood symptoms, mortality and treatment response. Therefore, this project aimed to investigate the impact of comorbid mental health disorders and age at onset on longitudinal psychosocial outcome in participants with BD.
METHOD
METHODS
Mixed effects modelling was conducted using data from the Stanley Foundation Bipolar Network. Baseline factors were entered into a model, with Global Assessment of Functioning (GAF) score as the longitudinal outcome measure. Relative model fits were calculated using Akaike's Information Criterion.
RESULTS
RESULTS
No individual comorbidities predicted lower GAF scores, however an interaction effect was demonstrated between attention deficit hyperactivity disorder (ADHD) and any anxiety disorder (t = 2.180, p = 0.030). Participants with BD I vs BD II (t = 2.023, p = 0.044) and those in the lowest vs. highest income class (t = 2.266, p = 0.024) predicted lower GAF scores. Age at onset (t = 1.672, p = 0.095) did not significantly predict GAF scores.
CONCLUSIONS
CONCLUSIONS
This is the first study to demonstrate the negative psychosocial effects of comorbid anxiety disorders and ADHD in BD. This study adds to the growing database suggesting that comorbid mental health disorders are a significant factor hindering psychosocial recovery.
Identifiants
pubmed: 31840207
doi: 10.1186/s40345-019-0169-5
pii: 10.1186/s40345-019-0169-5
pmc: PMC6911815
doi:
Types de publication
Journal Article
Langues
eng
Pagination
28Références
Arch Gen Psychiatry. 2007 May;64(5):543-52
pubmed: 17485606
Am J Addict. 2011 Jul-Aug;20(4):319-29
pubmed: 21679263
J Affect Disord. 2009 Apr;114(1-3):58-67
pubmed: 18708263
Am J Epidemiol. 2003 Jan 15;157(2):98-112
pubmed: 12522017
Psychopharmacol Bull. 2008;41(4):37-47
pubmed: 19015628
J Affect Disord. 2011 Mar;129(1-3):68-74
pubmed: 20832866
Bipolar Disord. 2007 Feb-Mar;9(1-2):103-13
pubmed: 17391354
Br J Psychiatry. 2006 Jul;189:20-5
pubmed: 16816301
J Atten Disord. 2008 Jan;11(4):445-58
pubmed: 18083961
World J Biol Psychiatry. 2010 Jun;11(4):656-66
pubmed: 20353313
Bipolar Disord. 2013 Feb;15(1):80-91
pubmed: 23301947
Depress Anxiety. 2014 Mar;31(3):196-206
pubmed: 24610817
Bipolar Disord. 2009 Jun;11(4):391-400
pubmed: 19500092
Am J Psychiatry. 2004 Dec;161(12):2222-9
pubmed: 15569893
Compr Psychiatry. 2017 Jul;76:169-176
pubmed: 28531646
Br J Psychiatry Suppl. 2001 Jun;41:s169-76
pubmed: 11450179
Prim Care Companion J Clin Psychiatry. 2010;12(3):null
pubmed: 20944770
J Psychopharmacol. 2016 Jun;30(6):495-553
pubmed: 26979387
BMJ. 2001 Nov 10;323(7321):1123-4
pubmed: 11701584
Bipolar Disord. 2018 Jun;20(4):303-312
pubmed: 29369448
Am J Psychiatry. 2002 Apr;159(4 Suppl):1-50
pubmed: 11958165
Compr Psychiatry. 2015 Jan;56:21-8
pubmed: 25284280
J Psychiatr Pract. 2014 Nov;20(6):428-37
pubmed: 25406047
Depress Res Treat. 2012;2012:949248
pubmed: 21961062
Arch Gen Psychiatry. 2011 Mar;68(3):241-51
pubmed: 21383262
Ann Clin Psychiatry. 2012 Feb;24(1):23-37
pubmed: 22303520
Psychiatry Res. 2008 Oct 30;161(1):36-42
pubmed: 18786727
Biol Psychiatry. 2003 Jul 1;54(1):1-8
pubmed: 12842302
CNS Spectr. 2017 Aug;22(4):325-332
pubmed: 26905615
Br J Psychiatry. 1995 May;166(5):654-9
pubmed: 7620753
Br J Psychiatry. 2014 Nov;205(5):362-8
pubmed: 25213156
Acta Psychiatr Scand. 2001 Mar;103(3):163-70
pubmed: 11240572
Psychiatr Serv. 2005 Apr;56(4):434-8
pubmed: 15812093
Subst Abuse Treat Prev Policy. 2007 Oct 01;2:29
pubmed: 17908301
J Pediatr. 2007 May;150(5):485-90
pubmed: 17452221
J Am Acad Child Adolesc Psychiatry. 2007 Nov;46(11):1445-53
pubmed: 18049294
J Affect Disord. 2012 Mar;137(1-3):161-4
pubmed: 22209124